Positioning the MIMS Group at the Core of Overseas Expansion

「In the overseas medical platform business, revenue growth was limited due to the impact of reduced marketing budgets at some customers and other factors. The global careers business posted a year-on-year decline in revenue, as the deterioration in the situation in the Middle East affected the cross-border travel of healthcare professionals, among other factors.」

「In the overseas medical platform business, revenue growth was limited due to the impact of reduced marketing budgets at some customers and other factors. The global careers business posted a year-on-year decline in revenue, as concerns over the situation in the Middle East affected the cross-border travel of healthcare professionals, among other factors. As a result, overseas revenue for the first half was ¥3,418 million, down 11.9% year on year.」

「In the overseas medical platform business, revenue growth was limited due to the temporary reduction of marketing budgets by some customers and other factors. Revenue growth in the global careers business was also limited due to a temporary suspension of visa issuance and changes in the situation in the Middle East, among other factors.」

「In the overseas medical platform business, orders for both digital and non-digital offerings remained firm, and the business continued to grow steadily. The global careers business also grew steadily, as referrals increased both domestically and across borders in existing markets. As a result, overseas revenue for the first half was ¥3,879 million, up 12.9% year on year.」

「The global careers business also grew significantly, driven by an increase in referrals in existing markets and contributions from Germany-based CWC and CF, which became subsidiaries in December 2022. As a result, overseas revenue for the fiscal year was ¥9,002 million, up 15.2% year on year.」

「In the overseas medical platform business, the lead time to revenue recognition lengthened as demand recovered for non-digital offerings such as live events, but delivery progressed during the third quarter of the fiscal year, and performance remained solid. The global careers business also grew significantly, driven by an increase in referrals in existing markets and contributions from Germany-based CWC and CF, which became subsidiaries in December 2022. As a result, overseas revenue for the nine-month period ended in the third quarter was ¥5,920 million, up 14.7% year on year.」

「The global career business grew significantly, driven by an increase in placements in existing operating countries and contributions from CWC and CF in Germany, which became subsidiaries in December 2022. As a result, revenue in the overseas segment for the cumulative second quarter of the fiscal year under review was ¥3,436 million, up 12.1% year on year.」

「The global career business grew significantly, driven by an increase in placements in existing operating countries and contributions from CWC and CF in Germany, which became subsidiaries in December 2022. As a result, revenue in the overseas segment for the cumulative first quarter of the fiscal year under review was ¥1,511 million, up 17.1% year on year.」

「The MIMS Group provides marketing support and other services for medical and healthcare-related businesses in 18 countries and regions across Asia, Oceania and other areas.」

「In the global career business, we made CWC Care with Care GmbH (CWC) and Care Forward GmbH (CF), two German companies engaged in cross-border nursing-staff placement and support for obtaining nursing qualifications, subsidiaries in December 2022. Through CWC and CF, we began cross-border staffing from Southeast Asia and other regions to Germany, and aim to expand into staffing within Germany in the future.」

「In the overseas segment, the medical platform business grew significantly. Although temporarily affected by lockdowns in China, digital adoption advanced amid the spread of COVID-19, and online events and digital products performed well. The global career business also grew significantly despite the impact of certain travel restrictions associated with the spread of COVID-19. As a result, revenue in the overseas segment for the cumulative second quarter of the fiscal year under review was ¥3,064 million, up 19.4% year on year.」

「In the overseas segment, the medical platform business grew significantly. Digital adoption advanced amid the spread of COVID-19, and online events and digital products performed well. The global career business also grew significantly despite the impact of certain travel restrictions associated with the spread of COVID-19. As a result, revenue in the overseas segment for the cumulative first quarter of the fiscal year under review was ¥1,290 million, up 25.1% year on year.」

「In the overseas segment, the medical platform business grew significantly. Digital adoption advanced amid the spread of COVID-19, and online events and digital products performed well. The global career business also grew significantly despite the impact of certain travel restrictions associated with the spread of COVID-19. As a result, revenue in the overseas segment for the cumulative third quarter of the fiscal year under review was ¥4,147 million, up 29.8% year on year.」

「In the overseas segment, the medical platform business grew significantly. Digital adoption advanced amid the spread of COVID-19, and online events and digital products performed well. The global career business also grew significantly despite the impact of certain travel restrictions associated with the spread of COVID-19. As a result, revenue in the overseas segment for the cumulative second quarter of the fiscal year under review was ¥2,567 million, up 36.1% year on year.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.8 million.」

「Healthcare-professional membership has reached approximately 2.8 million. Leveraging MIMS’s strong brand, healthcare-professional membership base, and business relationships with pharmaceutical companies and medical institutions, we provide marketing support and other services for medical and healthcare-related businesses.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.65 million. Leveraging MIMS’s strong brand, healthcare-professional membership base, and business relationships with pharmaceutical companies and medical institutions, we provide marketing support and other services for medical and healthcare-related businesses. Through the acquisition of Melorita, a Malaysian nursing-staffing company, in 2017, we fully launched the global career business, primarily supporting the cross-border placement and job changes of healthcare professionals with hospitals in the Middle East. We entered the Philippines in 2018 and Ireland and Australia in 2019, and will continue expanding the countries in which we provide services, establishing an overwhelming position globally in healthcare-professional placement.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.65 million. Leveraging MIMS’s strong brand, healthcare-professional membership base, and business relationships with pharmaceutical companies and medical institutions, we provide marketing support and other services for medical and healthcare-related businesses. Through the acquisition of Melorita, a Malaysian nursing-staffing company, in 2017, we fully launched the global career business, primarily supporting the cross-border placement and job changes of healthcare professionals with hospitals in the Middle East. We entered the Philippines in 2018 and Ireland and Australia in 2019, and will continue expanding the countries in which we provide services, establishing an overwhelming position globally in healthcare-professional placement. Going forward, we will strongly advance our overseas strategy by using MIMS as a platform for business expansion in Asia, Oceania and other regions, achieve further growth, and contribute to improving healthcare globally.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.65 million.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.65 million. Through the acquisition of Melorita, a Malaysian nursing-staffing company, in 2017, we fully launched the global career business, primarily supporting the cross-border placement and job changes of healthcare professionals with hospitals in the Middle East. We entered the Philippines in 2018 and Ireland and Australia in 2019, and will continue expanding the countries in which we provide services, establishing an overwhelming position globally in healthcare-professional placement.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.5 million. Leveraging MIMS’s strong brand, healthcare-professional membership base, and business relationships with pharmaceutical companies and medical institutions, we provide marketing support and other services for medical and healthcare-related businesses. In addition, we made Melorita, a Malaysian nursing-staffing company, a subsidiary in June 2017 and fully launched the global career business. We will expand the countries in which we operate from both the supply of healthcare professionals and the acquisition of recruitment orders from medical institutions, establishing an overwhelming number-one position globally in healthcare-professional placement. We also made MIMS a wholly owned subsidiary in September 2018 to accelerate decision-making and create greater synergies within our group. Going forward, we will strongly advance our overseas strategy by using MIMS as a platform for business expansion in Asia, Oceania and other regions, achieve further growth, and contribute to improving healthcare globally.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 17 countries and regions. In addition, we made Melorita, a Malaysian nursing-staffing company, a subsidiary in June 2017 and fully launched the global career business. We will expand the countries in which we operate from both the supply of healthcare professionals and the acquisition of orders from medical institutions, establishing an overwhelming number-one position globally in healthcare-professional placement. In August 2019, we also made CCM, headquartered in Ireland and engaged in placing healthcare professionals from Europe and Oceania with medical institutions in the Middle East, a subsidiary.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 15 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.5 million. Leveraging MIMS’s strong brand, healthcare-professional membership base, and business relationships with pharmaceutical companies and medical institutions, we provide marketing support and other services for medical and healthcare-related businesses. In addition, we made Melorita, a Malaysian nursing-staffing company, a subsidiary in June 2017 and fully launched the global career business. We will expand the global career business by leveraging MIMS’s membership base, our expertise in the career business, and Melorita’s cross-border operating expertise. We also made MIMS a wholly owned subsidiary in September 2018 to accelerate decision-making and create greater synergies within our group. Going forward, we will strongly advance our overseas strategy by using MIMS as a platform for business expansion in Asia, Oceania and other regions, achieve further growth, and contribute to improving healthcare within and outside Asia.」

「In addition, we made Melorita, a Malaysian nursing-staffing company, a subsidiary in June 2017 and fully launched the global career business. By making the MIMS Group a wholly owned subsidiary in September 2018, we will accelerate decision-making and create greater synergies within our group, while making the MIMS Group a platform for business expansion in Asia, Oceania and other regions to strongly advance our overseas strategy and achieve further growth.」

「Overseas, we made the MIMS Group, which provides medical-information services in Asia and Oceania, a subsidiary in October 2015, and currently provide services in 15 countries and regions. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.3 million. We also made Melorita, a Malaysian nursing-staffing company, a subsidiary in June 2017 and fully launched the global career business. By making the MIMS Group a platform for business expansion in Asia, Oceania and other regions, the full acquisition of the MIMS Group in the second quarter of the fiscal year under review will enable faster decision-making and create greater synergies within our group, while strongly advancing our overseas strategy and achieving further growth.」

「To expand the countries supplying healthcare professionals and accelerate the global expansion of the career business, we made MSR, a Philippine nursing-staffing company, a subsidiary in May 2018.」

「Overseas, we acquired the MIMS Group in October 2015. It provides medical-information services in Asia and Oceania and currently operates in 14 countries and regions. We fully launched the global career business through the acquisition of Melorita in June 2017. By making the MIMS Group a platform for business expansion in Asia and Oceania, we will strongly advance marketing support for pharmaceutical companies and the global career business and achieve further growth.」

「In October 2015, we acquired the MIMS Group, which provides medical-information services in 13 countries and regions across Asia and Oceania. The MIMS brand, founded in 1963 and with a history spanning more than 50 years, has overwhelming recognition in the region, and its healthcare-professional membership has reached approximately 2.3 million. Doctors in particular have high registration rates in many countries. The group has also leveraged its strong membership base to establish broad business relationships with pharmaceutical companies in the region. By making the MIMS Group a platform for business expansion in Asia and Oceania, we will strongly advance our overseas strategy and achieve further growth.」

「In June 2017, the MIMS Group made Melorita, a Malaysian nursing-staffing company with extensive hospital job orders in Saudi Arabia, Asia and other regions, a subsidiary. Leveraging its membership base of approximately 2 million healthcare professionals, the MIMS Group has begun developing a global career business that supplies the large pool of Asian healthcare professionals not only for job placement in their respective countries, but also within and outside Asia. The acquisition of Melorita secured placement destinations outside Asia. By combining the MIMS Group’s healthcare-professional membership base with our expertise in operating the career business, we will accelerate the growth of the global career business.」

「By making the MIMS Group a platform for business expansion in Asia and Oceania, we will strongly advance our overseas strategy and achieve further growth.」

「By making the MIMS Group a platform for business expansion in Asia and Oceania, we will strongly advance our overseas strategy and achieve further growth.」

「Within the MIMS Group’s existing businesses, initiatives are under way to move the Pharma Marketing business online. In its new businesses, the MIMS Group has begun test marketing for the career business.」

「By making the MIMS Group the core of business expansion in Asia and Oceania, we will strongly advance our overseas strategy and achieve further growth.」